ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025
Germline Disruption of Retinal Pigment Epithelium-Expressed Zebrafish rlbp1b
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The cone visual cycle and its disorders: insights from zebrafish.Frontiers in molecular neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cellular retinaldehyde binding protein (CRALBP) plays a crucial role in the visual cycle by chaperoning 11-cis-retinoids. Mutations in its encoding gene RLBP1 lead to inherited retinal diseases with the common feature of poor night vision. Zebrafish possess two RLBP1 paralogs, rlbp1a and rlbp1b, with distinct retinal expression profiles, providing a bespoke opportunity to dissect cell-specific functions of CRALBP. Here, we first resolved conflicting reports on paralog expression by interrogating zebrafish single-cell RNA-sequencing datasets, which revealed predominant rlbp1a expression in Müller glia and rlbp1b expression in the RPE. Using CRISPR-generated zebrafish knockouts, we demonstrated that loss of RPE-expressed rlbp1b selectively impaired optokinetic responses (OKR) with a ~50% reduction in saccade frequency relative to wildtype. This impaired OKR response is only seen when under dim light conditions with no defect seen in standard or bright light rearing conditions. This recapitulates the night blindness presentation in patients with RLBP1 mutations. Retinoid profiling of rlbp1b knockout larvae showed significant decreases in 11-cis-retinal (62% reduced) and all-trans-retinal (69% reduced) levels. To explore mechanistic changes following rlbp1b loss, unbiased proteomic profiling was carried out on rlbp1b knockout adult zebrafish eyes. This confirmed the knockout of Cralbpb and revealed significant disruption of proteins involved in vitamin A metabolism, lipid metabolism/storage and ferroptosis. To explore the utility of zebrafish for in vivo pathogenicity assessment of RLBP1, we established a complementation assay using transgenic zebrafish. Although expression of wildtype EGFP-tagged human RLBP1 did not rescue the visual deficit, expression of zebrafish Cralbp to the RPE restored dim light vision, whereas zebrafish Cralbp harboring the human pathogenic p.R151Q mutation failed to do so. Together, these findings underscore the predominant role of RPE-expressed CRALBP in sustaining visual function under low-light conditions and establish a zebrafish platform for functional evaluation of RLBP1 variants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.